Pharmacotherapy Specialty Core Therapeutic Module Package for Recertification (Cert # L229274)

 The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

These activities are intended for Board Certified Pharmacotherapy Specialists in need of recertification credit. 

Board certified pharmacists are eligible to receive 5.0 contact hours of recertification credit for completing this module. To earn recertification credit, learners must review the activity content and successfully complete the online assessment by the deadline. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment. 

Participants who pass the assessments will be eligible for recertification credit in the year in which the assessment was completed. 

These activities are part of the ASHP professional development program for BCPS recertification approved by the BPS. 

After participating in these CPE activities, learners should be able to:

Select Topics in Infectious Diseases: Part 1
ACPE#: 0204-0000-22-615-H01-P

For the following infectious diseases: c.difficile infection, skin and soft tissue infections, upper respiratory tract infections, community acquired pneumonia

• Interpret laboratory and diagnostic tests.
• Formulate the most appropriate treatment, monitoring, and follow-up plans based on patient-specific information and current guidelines.
• Evaluate drug-related problems. 

Select Topics in Infectious Diseases: Part 2
ACPE#: 0204-0000-22-616-H01-P

For the following infectious diseases: sexually transmitted diseases, urinary tract infections, endocarditis, meningitis

• Interpret laboratory and diagnostic tests.
• Formulate the most appropriate treatment, monitoring, and follow-up plans based on patient-specific information and current guidelines.
• Evaluate drug-related problems. 

Fluid, Electrolytes, and Nutrition
ACPE#: 0204-0000-22-617-H01-P

• Interpret laboratory and diagnostic tests for fluid, electrolyte, and nutrition status.
• Recommend the most appropriate therapy and monitoring in patients with fluid, electrolyte, and nutritional disorders based on patient-specific information and current guidelines.
• Apply strategies to manage drug-related electrolyte interactions and nutrient interactions. 

Select Topics in Neurologic Disorders
ACPE#: 0204-0000-22-618-H01-P

For patients with seizure disorders, Parkinson’s disease, headache and sleep disorders:

• Evaluate the risks and benefits of drug therapy considering other medication and patient specific factors.
• Formulate the most appropriate treatment, monitoring and follow-up plans based on patient-specific information and current guidelines.
• Evaluate drug-related problems. 

Diabetes
ACPE#: 0204-0000-22-619-H01-P

• Interpret diagnostic and/or laboratory tests in patients with diabetes.
• Formulate the most appropriate treatment, monitoring, and follow-up plans based on patient-specific information and current guidelines.
• Evaluate drug-related problems.

Faculty bios

Christopher Betz, Pharm.D., BCPS, FKSHP, FASHP*
Associate Professor, Clinical and Administrative Sciences
Sullivan University College of Pharmacy
Louisville, Kentucky

Snehal H. Bhatt, Pharm.D., BCPS*
Associate Professor of Pharmacy Practice
Massachusetts College of Pharmacy and Health Sciences
Clinical Pharmacist
Beth Israel Deaconess Medical Center
Boston, Massachusetts 

Lourdes Cross, PharmD, BCACP, CDCEs
Assistant Professor
Sullivan University College of Pharmacy & Health Sciences
Clinical Pharmacy Specialist
University of Louisville Hospital
Louisville, Kentucky 

Krutika Mediwala Hornback, PharmD, BCPS, BCIDP
Infectious Diseases/Antimicrobial Stewardship Clinical Pharmacy Specialist
Medical University of South Carolina (MUSC) Health
Infectious Diseases Pharmacy Residency Program Director
MUSC Health
Charleston, South Carolina 

Douglas Slain, Pharm.D., BCPS (AQ-ID), FCCP, FASHP*
Associate Professor and Infectious Diseases Clinical Specialist
West Virginia University School of Pharmacy
Morgantown, West Virginia

Diana Solomon, PharmD, BCCCP
Critical Care Clinical Pharmacy Specialist
St. Joseph’s Hospital and Medical Center
Phoenix, AZ 

Trent G. Towne, PharmD, BCPS
Associate Professor of Pharmacy Practice
Manchester University College of Pharmacy
Clinical Pharmacy Specialist, Infectious Disease
Parkview Health System
Fort Wayne, Indiana 

Jon Wietholter, PharmD, BCPS, FCCP
Clinical Associate Professor
West Virginia University School of Pharmacy
Internal Medicine Clinical Specialist
WVU Medicine Ruby Memorial Hospital
Morgantown, West Virginia

*Content matter experts

Anna M. Jackson, Pharm.D., BCPS
Tony Martin, Pharm.D., M.B.A.

Shelbi Adams, PharmD, BCPS
Rachel  Malta, PharmD, BCPS
Shaun Randa , PharmD, BCPS
Hakeem Abayomi , BS, PharmD, BCPS, BCPPS, BCIDPS
Brian LeBaron, PharmD, BCPS, ACHIP, FAMIA
Casey Motto, PharmD, BCPS
John Healey, PharmD, BCPS
George Piasare, PharmD, BCPS
Courtney Robertson, PharmD, BCPS, CLC
Heather Petrie, PharmD, MBA, BCPS
Ian Andrus, PharmD, MBA, BCPS
Heather Schalk, PharmD, BCPS
Jon Bachna, PharmD, MBA, BCPS
Surafel Mulugeta, PharmD, MS, BCPS
Maisie So, PharmD, BCPS
Daphne Bernardin, PharmD
Michael Barton, PharmD, BCPS, BCGP
Mollie VanNatta, PharmD, BCPS, BCIDP
Eric Kinney, PharmD, BCPS
Sirisha Kandepi, PharmD, BCPS
Charles Maina, PharmD BCPS
Julie Asmus, PharmD, BCPS
Jessica Hagy, PharmD, BCPS
Bridger Singer, PharmD, BCPS, BCCCP
Leslie Wooten, PharmD, BCPS
Craigg Barr, PharmD, BCPS
Carly McKenzie, PharmD, BCPS
Joseph Rackson, PharmD, BCPS
Christine Williams, PharmD, BCPS, BCOP
Kristin Watson, PharmD, BCCP
Vikki Huggins, PharmD, BCPS
Seth Lilly, PharmD, BCPS
Ann Chung, PharmD, BCPS
Matthew Morrison, PharmD, BCPS
Adrienne O'Brien, PharmD, BCPS
Tara Breuer, RPh, BCPS, BCSCP
Melanie Crass, PharmD, BCPS
Tyler Vest, PharmD, MS, BCPS, BCSCP
Joseph Volk, PharmD, BCPS

In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company. 

An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience. 

No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company. 

As required by the Standards of Integrity and Independence in Accredited Continuing Education, all relevant financial relationships have been mitigated prior to the CPE activity.

Activities which can be completed in any order. Each activity consists of audio, video, and/or PDFs and evaluations.  Learners must review all content and complete the evaluations to receive continuing pharmacy education credit for each activity. 

Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity. 

These activities were developed by ASHP.